Justin Schreiber sold $163k of LFMD
Chief Executive Officer at LifeMD, Inc.. 25,000 shares at an average of $6.52, traded Dec 2, 2024, filed Dec 4, 2024.
Score components
- +25RoleCEO
- +11Trade size$163k at market
- 0Share of holdings soldSold 0.9% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.8%, 3m -17.4%, 6m +103.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000912282-24-000853, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: by Schreiber Holdings LLC10b5-1 | -25,000 | $6.52 | $163k | 2,728,715 | Dec 4, 2024 |
| Dec 2, 2024 | JOther Common Stock10b5-1 | +0 | $0.00 | $0 | 200,000 | Dec 4, 2024 |
Related signals
Other insiders at LifeMD, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | LFMDsell LifeMD, Inc. | Jessica Friedeman Chief Marketing Officer | $54k 15,000 shares | -7% | |
| 37Weak | LFMDsell LifeMD, Inc. | Nicholas P Alvarez Chief Acquisition Officer | $444k 75,000 shares | -11% | |
| 18Weak | LifeMD, Inc. | Justin Schreiber Chairman and CEO | $250k 25,000 shares | -1% | |
| 20Weak | LifeMD, Inc. | Justin Schreiber Chairman and CEO | $334k 25,000 shares | -1% | |
| 52Moderate | LifeMD, Inc. | Marc David Benathen Chief Financial Officer | $1.7M 125,000 shares | -27% | |
| 55Moderate | LifeMD, Inc. | Stefan Galluppi Chief Innovation Officer | $1.1M 85,000 shares | -51% | |
| 52Moderate | LifeMD, Inc. | Eric Harold Yecies Chief Legal Officer & GC | $184k 15,000 shares | -48% | |
| 34Weak | LifeMD, Inc. | Justin Schreiber Chairman and CEO | $312k 25,000 shares | -1% | |
| 17Weak | LifeMD, Inc. | Justin Schreiber Chairman and CEO | $188k 25,000 shares | -1% | |
| 21Weak | LifeMD, Inc. | Justin Schreiber Chairman and CEO | $389k 50,000 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.